Walless has advised Lithuanian biotech startup Vugene on its EUR 1 million investment round led by Superhero Capital, with participation from NGL Ventures, Coinvest Capital, and a syndicate of angel investors. TGS Baltic reportedly advised Superhero Capital and Coinvest Capital.
According to Walless, the transaction will fuel Vugene's expansion of its multi-omics data analysis platform into new research markets. The company's platform enables scientists to interpret complex biological datasets across health and disease research.
The Walless team included Partners Andrius Ivanauskas and Mindaugas Lukas and Senior Associate Ieva Pikaite.
